Examining the distinct actions and advocacy that have advanced the concept from buzzword status to practical implementation in clinical studies. Since we started reporting on the topic of patient centricity back in 2014, we've kept track of how the subject has evolved. [...]Boehringer Ingelheim focused on investigating patient-centric efforts on remote trials, including leveraging digital opportunities (i.e., internet, social media, etc.) to recruit patients; using eConsent; collecting data remotely via biosensors; eMonitoring (i.e., leveraging risk-based monitoring on collected data); utilizing technology to engage patients (i.e., digital reminders, and digital access to study information); and pointed to a federal register docket on use of digital technology in clinical trials.9 In essence, BI was homing in on these initiatives to align its clinical trials with future patients, who will expect convenience and remoteness in study conduct. Moe Alsumidaie, MBA, MSF, is a thought leader and expert in the application of business analytics toward clinical trials, and Editorial Advisory Board member for and regular contributor to Applied Clinical Trials References 1. https://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm347317.htm 2. http://www.appliedclinicaltrialsonline.com/fdas-margaret-hamburgangle-patient-engagement-and-regulatory-systems-reform 3.